259 related articles for article (PubMed ID: 28884705)
1.
Habashy DM; Eissa DS; Aboelez MM
Turk J Haematol; 2018 Aug; 35(3):168-174. PubMed ID: 28884705
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
6. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
[TBL] [Abstract][Full Text] [Related]
7. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
10. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
Eisele L; Prinz R; Klein-Hitpass L; Nückel H; Lowinski K; Thomale J; Moeller LC; Dührsen U; Dürig J
Eur J Haematol; 2009 Oct; 83(4):320-7. PubMed ID: 19500131
[TBL] [Abstract][Full Text] [Related]
11. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
[TBL] [Abstract][Full Text] [Related]
13. Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
Molica S; Digiesi G; Mirabelli R; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Morabito F; Neri A; Baldini L; Ferrarini M
Eur J Haematol; 2009 Sep; 83(3):208-14. PubMed ID: 19459926
[TBL] [Abstract][Full Text] [Related]
14. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
[TBL] [Abstract][Full Text] [Related]
15. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.
Oppezzo P; Vasconcelos Y; Settegrana C; Jeannel D; Vuillier F; Legarff-Tavernier M; Kimura EY; Bechet S; Dumas G; Brissard M; Merle-Béral H; Yamamoto M; Dighiero G; Davi F;
Blood; 2005 Jul; 106(2):650-7. PubMed ID: 15802535
[TBL] [Abstract][Full Text] [Related]
16. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
17. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.
Ocaña E; Delgado-Pérez L; Campos-Caro A; Muñóz J; Paz A; Franco R; Brieva JA
Haematologica; 2007 Mar; 92(3):349-56. PubMed ID: 17339184
[TBL] [Abstract][Full Text] [Related]
19. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
Nückel H; Hüttmann A; Klein-Hitpass L; Schroers R; Führer A; Sellmann L; Dührsen U; Dürig J
Leuk Lymphoma; 2006 Jun; 47(6):1053-61. PubMed ID: 16840197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
